These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6821712)

  • 1. Studies on a family with the factor VII defect.
    Zwierzina WD; Kunz F; Glatzl J
    Blut; 1983 Jan; 46(1):47-55. PubMed ID: 6821712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis.
    Triplett DA; Brandt JT; Batard MA; Dixon JL; Fair DS
    Blood; 1985 Dec; 66(6):1284-7. PubMed ID: 4063521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the nature of mildly prolonged prothrombin times.
    Mazzucconi MG; Mariani G; Chistolini A; Lasagni RP; Motta M; Ghirardini A; Altieri D; Mannucci PM; Mandelli F
    Am J Hematol; 1987 Jan; 24(1):37-45. PubMed ID: 3799594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A.
    Girolami A; Dal Bo Zanon R; Fabris F; Franzoso R
    Acta Haematol; 1977; 58(4):246-54. PubMed ID: 410227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier detection in factor VII congenital deficiency.
    Mariani G; Hermans J; Orlando M; Mazzucconi MG; Ciavarella N; Faiella A; Berrettini M; Chistolini A; Di Nucci GD; Mannucci PM
    Br J Haematol; 1985 Aug; 60(4):687-94. PubMed ID: 4027194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VII Padua defect: the heterozygote population.
    Girolami A; Dal Bo Zanon R; Zanella F; Procidano M; Ruffato G
    Acta Haematol; 1982; 68(1):34-8. PubMed ID: 6812354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of different factor VII deficiency variants in nine families from Spain.
    Pardo A; Oteyza JP; Blanco L; Correa MA; Cesar J; Steegman JL; Tamayo M; Fernandez I; Escribano L; Navarro JL
    Haemostasis; 1987; 17(5):268-72. PubMed ID: 3666584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects.
    Girolami A; Pontara E; Dannhauser D; Bertomoro A; Ferasin S; Piccolo M; Casonato A
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):177-81. PubMed ID: 8457648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor VII congenital deficiency. Clinical picture and classification of the variants.
    Mariani G; Mazzucconi MG
    Haemostasis; 1983; 13(3):169-77. PubMed ID: 6350122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VII deficiency: immunological characterization of genetic variants and detection of carriers.
    Mariani G; Mazzucconi MG; Hermans J; Ciavarella N; Faiella A; Hassan HJ; Mannucci PM; Nenci GG; Orlando M; Romoli D; Mandelli F
    Br J Haematol; 1981 May; 48(1):7-14. PubMed ID: 7248191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and comparison of immune-depleted and hereditary factor-VII-deficient plasmas as substrate plasmas for factor VII assays.
    Brandt JT; Triplett DA; Fair DS
    Am J Clin Pathol; 1986 May; 85(5):583-9. PubMed ID: 3518398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma.
    Poller L; Thomson JM; Sear CH; Thomas W
    J Clin Pathol; 1971 Oct; 24(7):626-32. PubMed ID: 5165796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VII and haemostasis: interaction between abnormal factors VII and tissue thromboplastins.
    Girolami A; Simioni P; Steffan A
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):749-50. PubMed ID: 2133255
    [No Abstract]   [Full Text] [Related]  

  • 14. Congenital factor VII deficiency. Clinical and laboratory characteristics of a newly discovered kindred.
    Kernoff LM; Hughes J; Denson KW
    Clin Lab Haematol; 1982; 4(2):109-15. PubMed ID: 7116793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.
    Tran HT; Tjønnfjord GE; Holme PA
    Haemophilia; 2014 Jan; 20(1):141-6. PubMed ID: 23992369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CRM-Positive variant of factor-VII deficiency and the detection of heterozygotes with the assay of factor-like antigen.
    Mazzucconi MG; Mandelli F; Mariani G; Briët E; Veltkamp JJ
    Br J Haematol; 1977 May; 36(1):127-35. PubMed ID: 871417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)".
    Girolami A; Scandellari R; Lombardi AM
    Semin Thromb Hemost; 2010 Feb; 36(1):123-4; author reply 125-7. PubMed ID: 20391303
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significant decrease in factor VII activity by tissue thromboplastin derived from rabbit brain in a patient with congenital factor VII deficiency (FVII Padua)].
    Sekiya A; Morishita E; Maruyama K; Asakura H; Nakao S; Ohtake S
    Rinsho Ketsueki; 2012 Mar; 53(3):357-60. PubMed ID: 22499055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
    Girolami A; Bertozzi I; de Marinis GB; Bonamigo E; Fabris F
    Hematology; 2011 Sep; 16(5):308-12. PubMed ID: 21902896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency.
    Goodnight SH; Feinstein DI; Osterud B; Rapaport SI
    Blood; 1971 Jul; 38(1):1-8. PubMed ID: 5558158
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.